Bronholitin - a herbal remedy used to treat diseases of the bronchi and lungs.

Pharmacological action

Bronholitin - a combined drug, has antitussive effect, improves patency of the respiratory tract.

Active ingredients bronholitin - basil oil, glaucine ephedrine. Oil basil has a weak sedative antispasmodic, antimicrobial effect. Glaucine suppresses coughing and Ephedrine dilates the bronchi, removes swelling of the bronchial mucosa, stimulates respiration.

Product form

Producing Bronholitin syrup in bottles.

Indications bronholitin

Bronholitin instructions for use as a means of cough suppressant and dilates the bronchi, with:

  • chronic and acute bronchitis,
  • whooping cough, tracheobronchitis
  • bronchopneumonia,
  • chronic obstructive lung disease,

There are reviews of bronholitin successfully applied when wheeze states.

 Bronholitin syrup
 Instructions for use bronholitin

Bronholitin for instructions take 1 st.lozh. three or four p / day.

Babies 3-10l Bronholitin syrup provide for 1st h / lodges 3 p / day and children over 10 liters - 2 hours / lodges and 3 p / day.

side effects

Application bronholitin can cause tachycardia, dizziness, high blood pressure, nausea, anorexia, vomiting, constipation, difficulty urinating, rashes on the skin, urinary retention (in patients with prostatic hypertrophy), increased sweating, blurred vision, tachyphylaxis, arrhythmia, arterial hypertension, dizziness, insomnia, agitation, tremors, various allergic reactions.

Children Bronholitin syrup can cause drowsiness. Also, judging by the reviews Bronholitin may contribute dysmenorrhea, increase in libido.

If not follow the instructions and bronholitin arisen as a consequence of an overdose may experience these symptoms: limb tremor, vomiting, nausea, dizziness, circulatory, urinary retention, excitation, suppression of appetite. In overdose syrup appointed gastric lavage.

Contraindications bronholitin

Application bronholitin contraindicated in coronary atherosclerosis, hyperthyroidism, insomnia, angina, arterial hypertension, glaucoma closure, chronic heart failure, hypertrophy of the prostate gland, pheochromocytoma. Also, do not prescribe Bronholitin syrup for children up to 3 years old, in pregnancy (1st trimester) and breastfeeding.

Judging by the reviews Bronholitin should be used with caution in patients who are prone to the emergence of drug dependence.

In an application with sympatholytics Bronholitin reduces their hypotensive effect.